Prevalence of Hepatitis B and C in Blood Bank Donors in SVNGMC Yavatamal

Snehal Jumnake, Jayawant Mahadhani, Sanjay Khandekar, Nilima Lodha, Snehalata Hingway


Background: Infections caused by the hepatitis B virus (HBV) and hepatitis C virus (HCV) are global public health problems. The safety of donated blood can be estimated by monitoring the prevalence of viral markers in the donor population. The present study was carried out in Yavatmal region of Maharashtra state, with an objective to determine the prevalence of HBV and HCV among blood bank donors.

Methods: Over a period of three years (January 2014 to December 2016), a total of 33082 blood units were collected from healthy voluntary and replacement blood donors. The donated units were serologically screened for hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (anti-HCV).

Results: Out of total blood donors, 93.67% were males and 6.32% were females. HBsAg was positive in 284 (0.85%) of the blood units that were collected, the blood units with anti–HCV seropositivity had the lowest prevalence (n=9, 0.027%) and these prevalence being higher in males than females. The prevalence of HBsAg was highest in the year of 2015 (0.93%) compared to 2014 (0.85) and 2016 (0.78). There was decline in the prevalence of HCV infection has been observed, from 0.039% in 2014 to 0.016% in 2016.

Conclusion: The study reveals that the decrease in HBV and HCV prevalence among blood bank donors in SVNGMC Yavatmal might be associated with the introduction of immunization programs, and an increased awareness of hepatitis B throughout the country.


Hepatitis B virus, Hepatitis C virus, Voluntary, Replacement, Hepatitis B surface antigen

Full Text:



. Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004; 70(1):15–28.

. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunology features of hepatic injury and viral persistence. Hepatology. 1999; 30(3):595–601.

. Mahoney FJ. Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection. Clin Microbiol Rev. 1999; 12(2):351–366.

. Blumberg BS. Australia antigen and the biology of hepatitis B. Sci. 1977; 197(4298):17–25.

. Purcell RH. The discovery of the hepatitis viruses. Gastroenterology. 1993; 104(4):955–963.

. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Gu¨nther S, et al. Serological pattern ‘anti-HBc alone’: report on a workshop. J Med Virol. 2000; 62(4): 450–455.

. Behzad-Behbahani A, Mafi-Nejad A, Tabei SZ, Lankarani KB, Torab A, Moaddeb A. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus. Indian J Med Res. 2006; 123(1): 37–42.

. Badur S, Akgun A. Diagnosis of hepatitis B infections and monitoring of treatment. J Clin Virol. 2001; 21(3):229–237.

. Vitale F, Tramuto F, Orlando A, VizziniG Melo V, Cerame G, Mazzucco W, et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol. 2008; 80(4): 577–582.

. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: 1685-1690.

. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(5):359–362.

. Alfredo A, Patrizia P, Chamellon L, Benvegnu L, Belussi F, DeMitiri MS. The interaction between hepatitis B and C viruses in acute and chronic liver disease. J Hepatol. 1995; 22(1):38–41.

. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.

. WHO, (2010). Sixty-Third World Health Assembly. 25 March

. World Health Organization: Hepatitis B Fact sheet N°204 July (2012). ctsheets/fs204/en/.

. Ayoola AE, Tobaigy MS, Gadour MO, Ahmed BS, Hamza MK. The decline of HBV viral infection in South-Western Saudi Arabia. Saudi Med J. 2003; 24(9):991–995.

. Al-Faleh FZ, Ayoola A, Al-Jeffry M, Arif M, Al-Rahsed R, Ramia S. Integration of hepatitis B vaccine into the expanded program on immunization: the Saudi Arabian experience. Ann Saudi Med. 1993; 13(3):231–236.

. Yong-lin Yang, Qiang Fu, Ming-shun Zhang, Jie Cai, Gui-ming Ma, Zu-hu Huang, et al. Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virol J. 2012; 9(82):1–6.

. Singh, B., Verma, M., Verma, K. Markers for transfusion-associated hepatitis in North India blood donors: prevalence and trends. Jpn J Infect Dis. 2004; 57(2):49–51.

. Van der Poel CL, Janssen MP, Borkent-Raven B. The collection, testing and use of blood and blood products in Europe in 2005. Final Report for the Council of Europe; 2009.

. Zou S, Stramer SL, Notari EP, Kuhns MC, Krysztof D, Musavi F, et al. Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 2009; 49(8): 1609–1620.

. Cisneros-Castolo M, Ndez-Ruiz LH, Ibarra-Robles IE, Ferna´ Ndez-GA´ Rate IH, Jorge Escobedo-DE LA Pen˜ A. Prevalence of hepatitis b virus infection and related risk factors in a rural community of Mexico. Am. J. Trop. Med. Hyg 2001; 65(6):759–763.

. Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976–1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998; 178: 954–959.

. Viel JF, Fest T, Dussaucy A, Pobel D, Agis F. Hepatitis B virus infection on a tropical island: sociodemographic and geographic risk factors in Guadeloupe. Am J Trop Med Hyg 1995; 52: 398– 402.

. Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan, over a 26-year period. Am J Trop Med Hyg 1998; 59: 693–698.

. Martinson FEA, Weigle KA, Royce RA, Weber DJ, Suchindran CM, Lemon SM. Risk factors for horizontal transmission of hepatitis B virus in a rural district in Ghana. Am J Epidemiol 1998; 147: 478–487.

. Allain JP. Occult hepatitis B virus infection Transfus Clin Bio 2004; 11: 18-25.


Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


  • There are currently no refbacks.

Copyright (c) 2017 International Journal of Biomedical Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.